pharma news, views and analysis - pharmaphorum.com

Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Data backs AZ’s Wilson disease drug, but with a question mark

Fujifilm acquires AI tech to improve fertility treatment

Sarepta shares yo-yo as FDA places hold on Duchenne trial

New countries stockpile antiviral TPOXX as monkeypox outbreak continues

Biogen and Happify partner on digital support for MS patients

AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

in News

Data backs AZ’s Wilson disease drug, but with a question mark

June 24, 2022 Share

X

Data backs AZ’s Wilson disease drug, but with a question mark

https://pharmaphorum.com/news/data-backs-azs-wilson-disease-drug-but-with-a-question-mark/

Last year, AstraZeneca reported that a new drug to treat Wilson disease developed by its Alexion rare diseases

in News

Sarepta shares yo-yo as FDA places hold on Duchenne trial

June 24, 2022 Share

X

Sarepta shares yo-yo as FDA places hold on Duchenne trial

https://pharmaphorum.com/news/sarepta-shares-yo-yo-as-fda-places-hold-on-duchenne-trial/

Shares in Sarepta came under pressure after the biotech said it had temporarily halted a clinical trial of

Latest News

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Precision Bio climbs on near-$1.5bn sickle cell pact with Novartis

Novartis has shouldered its way into the in vivo gene editing category via a deal with US biotech

X

Precision Bio climbs on near-$1.5bn sickle cell pact with Novartis

https://pharmaphorum.com/news/precision-bio-climbs-on-near-1-5bn-sickle-cell-pact-with-novartis/

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

Moderna says COVID booster works against Omicron subvariants

Moderna has reported top-line data suggesting that its COVID-19 booster vaccine candidate stimulates a strong immune response against

X

Moderna says COVID booster works against Omicron subvariants

https://pharmaphorum.com/news/moderna-says-covid-booster-works-against-omicron-subvariants/

moderna

Moderna facility in UK confirmed, part of 10-year deal with gov’t

Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead

X

Moderna facility in UK confirmed, part of 10-year deal with gov’t

https://pharmaphorum.com/news/moderna-facility-in-uk-confirmed-part-of-10-year-deal-with-govt/

Views & Analysis

stockpile antiviral TPOXX monkeypox

New countries stockpile antiviral TPOXX as monkeypox outbreak continues

pharmaphorum editor in chief Jonah Comstock talks to Philip Gomez, CEO of Siga Technologies, about how his company’s

X

New countries stockpile antiviral TPOXX as monkeypox outbreak continues

https://pharmaphorum.com/r-d/new-countries-stockpile-antiviral-tpoxx-as-monkeypox-outbreak-continues/

forecasting

Evaluate’s Orphan Drug Report shows rapid acceleration in the space

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the

X

Evaluate’s Orphan Drug Report shows rapid acceleration in the space

https://pharmaphorum.com/market-access-2/evaluates-orphan-drug-report-2022/

drug development

FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials

China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates

X

FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials

https://pharmaphorum.com/market-access-2/fdas-treatment-of-china-developed-drugs-spurs-demands/

Debates & Insights

Sensyne Health Webinar

Synthetic control arms in clinical trials: Making it happen

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges

X

Synthetic control arms in clinical trials: Making it happen

https://pharmaphorum.com/webinars/synthetic-control-arms-in-clinical-trials-making-it-happen/

Print

Customer engagement and pharma’s field force future

How healthcare professionals (HCPs) prefer to engage with pharma companies has been changing for some time, and COVID’s

X

Customer engagement and pharma’s field force future

https://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/

SAVANA_webinar_holding_slide-23.03.21-1200x675

AI, big data and deep real-world evidence – the challenges and opportunities

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights

X

AI, big data and deep real-world evidence – the challenges and opportunities

https://pharmaphorum.com/webinars/ai-big-data-real-world-evidence-savana/

Partner Content

ARDS Pharmaphorum Banners

2nd ARDS Drug Development Summit

Only Industry-Specific Event for ARDS Drug Developers

X

2nd ARDS Drug Development Summit

https://pharmaphorum.com/events/2nd-ards-drug-development-summit/

mRNA- Based Therapeutics Summit Europe

Uniting 150+ mRNA Leaders to Progress the mRNA Field

X

mRNA- Based Therapeutics Summit Europe

https://pharmaphorum.com/events/mrna-based-therapeutics-summit-europe/

Transdermal and Microneedle Drug Delivery

Transdermal and Microneedle Drug Delivery

Latest innovations in drug delivery beyond the needle

X

Transdermal and Microneedle Drug Delivery

https://pharmaphorum.com/events/transdermal-and-microneedle-drug-delivery/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Novartis faces threat of early generic of MS drug Gilenya in US
Novartis bags FDA okay for BRAF-positive tumour combination
Pfizer is first big pharma to tap Truveta's real-world data platform
AbbVie files Qulipta for chronic migraine prevention
Moderna facility in UK confirmed, part of 10-year deal with gov't

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com